Resmed
ResMed is a global leader in the design, manufacture, and distribution of medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders, including sleep apnea, COPD, and other chronic diseases. The company's core business revolves around providing innovative solutions for improving the quality of life for people with respiratory conditions, holding a significant market share in the sleep apnea treatment market.
Short position
Resmed (ASX:RMD) has 0.44% of its shares on issue reported as short positions as of 5 Oct 2026, or about 2,484,851 shares. Over the past 30 days that figure has fallen 0.12 percentage points, and over 90 days it has risen 0.08 percentage points. Its highest recorded short interest was 3.10% in October 2014. RMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4RMD community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to RMD.
Start the first RMD research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.